Projects

Project overview (since 2010-01-01):

			next >>
Start date	Project	acronym	role	funding	partners
2023-01-01	Early Interception of Inflammatory-mediated Type 2 Diabetes	INTERCEPT-T2D	participant	8.090.973	13
2023-01-01	CArdiovascularREsolution of INflammation to promote HEALTH	CARE-IN-HEALTH	participant	6.993.397	10
2022-07-01	SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients	HERVCOV	participant	6.846.157	9
2022-06-01	Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness	BE READY	participant	1.998.894	23
2022-02-01	Integrated Services for Infectious Disease Outbreak Research	ISIDORe	participant	20.998.624	154
2021-06-01	Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial	RITA-MI 2	participant	6.583.216	14
2021-03-01	Working collaboratively with vulnerable women to identify the best implementation gains by screening cervical cancer more effectively in European countries	CBIG-SCREEN	participant	3.661.850	16
2020-08-01	Modern approaches for developing antivirals against SARS-CoV 2	MAD-CoV 2	participant	3.749.669	9
2020-07-01	European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases	EU-RESPONSE	participant	15.719.450	27
2020-04-01	Corona Accelerated R&D in Europe	CARE	participant	36.559.186	43
2020-01-01	Impact of exposome on the course of lung diseases	REMEDIA	participant	11.134.616	17
2020-01-01	Brain injury in the premature born infant: stem cell regeneration research network	PREMSTEM	participant	8.999.620	16
2020-01-01	Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility	miniNO	participant	6.487.770	12
2020-01-01	Immune profiling to guide host-directed interventions to cure HBV infections	IP-cure-B	participant	9.983.029	16
2020-01-01	FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA	FAIR	participant	10.162.904	15
2020-01-01	Human Gonad Developmental Cell Atlas	HUGODECA	participant	4.822.197	10
2020-01-01	Gene Therapy to restore lymphatic flow lymphedema	TheraLymph	participant	8.064.946	11
2019-07-01	Antibiotic Distribution and Recovery in Tissue	AB-DiRecT	participant	3.429.217	6
2019-03-01	CARdiomyopathy in type 2 DIAbetes mellitus	CARDIATEAM	participant	6.700.000	21
2019-01-01	European Joint Programme on Rare Diseases	EJP RD	participant	55.073.831	88
2019-01-01	Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics	VHFMoDRAD	participant	3.316.013	14
2019-01-01	Integrating Environment and Health Research: a Vision for the EU	HERA	participant	3.097.323	23
2019-01-01	Advancing European Research Infrastcuture on Highly Pathogenic Agents	ERINHA-Advance	participant	3.746.804	12
2019-01-01	An integrative strategy of testing systems for identification of EDs related to metabolic disorders	OBERON	participant	5.978.763	12
2018-01-01	The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients	EU-TRAIN	participant	6.641.546	13
2018-01-01	Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative	R-LiNK	participant	7.702.532	22
2017-01-01	Crimean-Congo Haemorrhagic Fever Vaccine	CCHFVaccine	participant	5.979.607	14
2016-10-01	A global alliance for Zika virus control and prevention	ZIKAlliance	participant	11.964.209	56
2016-01-01	European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates	EHVA	participant	22.188.522	43
2016-01-01	Investigating the impact of meditation training on mental health and wellbeing in the ageing population	MEDIT-AGEING	participant	6.134.756	11
2016-01-01	European Research Infrastructure on Highly Pathogenic Agents 2	ERINHA2	participant	1.443.927	16
2015-11-01	Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases	JPsustaiND	participant	2.043.284	16
2015-09-01	Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients	MIROCALS	participant	5.980.435	12
2015-05-01	Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension	ENSAT-HT	participant	7.607.337	13
2015-05-01	Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone	FAIR-PARK-II	participant	5.998.994	15
2014-02-01	Nanotherapeutics for antibiotic resistant emerging bacterial pathogens	NAREB	participant	9.674.158	15
2014-02-01	Anti-Parasitic Drug Discovery in Epigenetics	A-PARADDISE	participant	5.999.991	16
2013-11-01	Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders	BRAINTRAIN	participant	5.998.661	10
2013-10-01	"Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis"	MYASTERIX	coordinator	5.900.720	5
2013-10-01	"Human pluripotent stem cell differentiation, safety and preparation for therapeutic transplantation in Huntington’s disease"	REPAIR-HD	participant	6.000.000	9
2013-09-01	Targeting cardiac fibrosis for heart failure treatment	FIBRO-TARGETS	participant	6.000.000	11
2013-09-01	Point-of-care tests to revolutionise the clinical management of patients infected by Hepatitis C virus	POC-HCV	participant	5.991.426	5
2013-07-01	Developing Innovative Outreach and Dialogue on responsible nanotechnologies in EU civil society	NANODIODE	participant	1.899.842	14
2013-03-01	Biomarkers of renal graft injuries in kidney allograft recipients	BIOMARGIN	participant	6.000.000	13
2013-02-01	Heart OMics in AGEing	HOMAGE	participant	12.000.000	18
2013-02-01	Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility	NANOATHERO	participant	9.833.348	16
2013-01-01	SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING	AGEDBRAINSYSBIO	participant	6.000.000	14
2012-11-01	Metagenomics in Cardiometabolic Diseases	METACARDIS	participant	11.999.992	15
2012-10-01	Highlighting EU-funded Health research results via TV media and the internet	HIGHLIGHT	participant	999.490	6
2012-10-01	Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes	DIABIL-2	participant	5.900.000	6
			next >>